Logo_Anaqua-Color.png
Anaqua Transforms Foreign Patent Filing into a Strategic Advantage for Intellectual Property Professionals
April 18, 2024 07:00 ET | Anaqua
Anaqua revolutionizes IP management with enhanced Foreign Filing in AQX®, empowering swift global protection decisions.
MNPR Triangle 2.JPG
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
April 16, 2024 08:00 ET | Monopar Therapeutics Inc.
WILMETTE, Ill., April 16, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer...
Logo_Anaqua-Color.png
Isuzu Motors Limited Drives Forward with Anaqua as Intellectual Property Management Provider
April 16, 2024 08:00 ET | Anaqua
Anaqua announces global commercial vehicle manufacturer Isuzu Motors as new intellectual property management software client.
PharmAla Biotech Logo 800 x 422.png
PharmAla Announces Private Placement and Concurrent Debt Settlement
April 10, 2024 16:30 ET | PharmAla Biotech
PharmAla Initiates $750,000 Private Placement with concurrent debt settlement, anticipated to close on April 17th 2024
Acri Capital Acquisition Corporation Announces Confidential Submission of Draft Registration Statement on Form S-4 and Extension of the Deadline for an Initial Business Combination
April 10, 2024 16:30 ET | Acri Capital Acquisition Corporation
Austin, Texas, April 10, 2024 (GLOBE NEWSWIRE) -- Acri Capital Acquisition Corporation (the “Company”) (Nasdaq: ACAC), a special purpose acquisition company, today announced that, in relation to its...
Picture3.jpg
Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders
April 10, 2024 07:17 ET | Clearmind Medicine Inc.
Vancouver, Canada, April 10, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "company"), a clinical- stage biotech company focused on discovery and...
TOME-Logo-RGB.png
Tome Biosciences Announces US Patent Issued for Integrase-Mediated Programmable Genomic Integration
April 09, 2024 08:08 ET | Tome Biosciences
Tome granted US patent for programmable genomic integration.
Logo_Anaqua-Color.png
Anaqua améliore sa plateforme de recherche de brevets AcclaimIP en ajoutant des capacités basées sur l'IA
April 08, 2024 09:37 ET | Anaqua
BOSTON, 08 avr. 2024 (GLOBE NEWSWIRE) -- Anaqua, le leader des technologies de gestion de la propriété intellectuelle (PI) et de l’innovation, continue d'améliorer sa puissante plateforme de...
Logo_Anaqua-Color.png
Anaqua Enhances AcclaimIP Patent Search with AI-Powered Capabilities
April 08, 2024 09:37 ET | Anaqua
Anaqua revolutionizes patent search with AI-powered AcclaimIP. Explore over 100M patents worldwide with user-friendly interface and cutting-edge AI.
Draft resolutions of
Draft resolutions of the Annual General Meeting of Akcinė prekybos bendrovė “APRANGA” shareholders to be held on 30th April 2024
April 03, 2024 10:20 ET | Apranga
Draft agenda and draft resolutions for the Annual General Meeting of Akcinė prekybos bendrovė “APRANGA” (hereinafter “Company”) shareholders to be held on 30th April 2024 proposed by the Board of the...